Sirona Biochem Corp. Stock
Your prediction
Pros and Cons of Sirona Biochem Corp. in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Sirona Biochem Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Sirona Biochem Corp. | - | - | - | - | - | - | - |
| Northwest Biotherapeutics Inc. | 0.000% | -12.000% | -26.667% | -34.000% | -35.922% | -72.840% | -86.931% |
| Larimar Therapeutics Inc. | -1.130% | 10.759% | 24.113% | 12.179% | 5.422% | -3.846% | -58.333% |
| Achieve Life Sciences Inc. | 1.830% | 3.738% | 0.909% | 154.005% | 50.000% | 12.805% | -8.264% |
Comments
News
Is Dentsply Sirona Stock a Buy After a Company Director Purchased 15,000 Shares?
Gregory T. Lucier, a member of the Board of Directors of Dentsply Sirona (NASDAQ:XRAY), reported the purchase of 15,000 shares of common stock at an average price of $12.45 per share on March 9
